David Cheng

Cancer epidemiologist. Studying precision cancer prevention and cancer health disparities. @jnci_now

[The Ohio State University Wexner Medical Center @OSUWexMed]

Pelotonia announced an annual fundraising total of $29,212,864 in 2025, bringing all-time funds raised to $339,074,826 for innovative cancer research at @OSUCCC_James. https://t.co/UmiKB9FOYz

[David Cheng @Cheng15]

En Cheng visited OSU and presented his research on body composition. Fascinating presentation and discussion! @EnCheng23 @OSUCCC_James

[David Cheng @Cheng15]

@LCottler Congratulations Linda! And wonderful to see you and Matt in Columbus!

[Hugh Kearns @ithinkwellHugh]

September 16-20 is National Postdoc appreciation week. #NPAW2024
https://t.co/pOHAT0N9QY

[Eric Topol @EricTopol]

Tricking the animal model that it is getting excess nutrients leads to inflammation, organ damage, and shortened lifespan, reversed by anti-inflammatory Rx
https://t.co/gvxgceAWWP @NatureAging @AnaOrtegaMolin1 @EfeyanLab @CNIOStopCancer @AgEInves @SaludISCIII @justsaysinmice

[JAMA Oncology @JAMAOnc]

Most viewed in the last 7 days from @JAMAOnc:

Is there an association between body composition metrics automatically extracted from imaging and prognoses in patients with advanced NSCLC receiving systemic therapy?

https://t.co/hyzhQAfZtt

[Sara Tolaney @stolaney1]

RxPONDER: outcomes by race+ ethnicity (n=3102), median f/u 8 yrs (5% NH Black, 70% NH White)

Worse outcome for NH Blacks c/w NH whites

NH Blacks have higher mean proliferation axis score c/w NH Whites , but BMI may also have a role

@OncoAlert #ASCO24 #bcsm

[Sara Tolaney @stolaney1]

Carolina Breast Cancer Study: assoc between MHC I +II and race. (total n=1630, 787=black; 68% HR+/HER2-) presented by Sonya Reid

MHCI + II more common in black in HR+/HER2- BC (this could potentially translate into improved response to IO)

@OncoAlert #bcsm #ASCO24

[Pelotonia Institute for Immuno-Oncology @OhioStatePIIO]

Excited to hear Dr. Ephraim Ansa-Addo's presentation on modulating #TregCells for #cancer #immunotherapy during our #PIIO Research-in-Progress! His research focuses on defining the functions of various subsets of #TregCells in the #TME & how they affect cancer progression.

[NIH Intramural @IRPatNIH]

Close out Asian American, Native Hawaiian, and Pacific Islander Heritage Month by listening to our new #SpeakingofScience episode! We break down some of the history that has shaped #AANHPI experiences and perspectives and explain why researchers like Dr. Jacqueline Vo are working to dismantle the myth that these populations are a monolithic group. Hear the full episode: https://t.co/TMzaugctbl #NIH_IRP

[Ohio State Medical Oncology @OhioStateMedOnc]

Join our @OhioStateMedOnc faculty at #ASCO24 to learn about our latest research!
@AshishManne @shafiarahman_ @StoverLab @CPresGeriOncMD

[Cancer Prevention Research @CAPR_AACR]

Read the article by the recipients of the Cancer Prevention Research Award for Outstanding Journal Article, Denise Cecil et al.—
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors & Increase the Influx of Type I Tumor-infiltrating Lymphocytes.
https://t.co/quyZZqjLub

[Minority Health @MinorityHealth]

A7: @NCIEpiTraining explains that disaggregated data can reveal variations in health disparities experienced by #AAs & #NHPIs and can help avoid making misleading conclusions about AA and NHPI health: https://t.co/OWByXOE4nY #SourceForBetterHealth (1/2)

[Elshad Hasanov, MD, PhD @HasanovLab]

🔍 Hiring Alert: We’re seeking bioinformaticians at various levels to elevate our translational research at @HasanovLab @OhioStatePIIO Join us in navigating the complexities of data to unveil groundbreaking findings 🧬🖥️ Your RTs to spread the word are greatly appreciated 🙏

[Pelotonia Institute for Immuno-Oncology @OhioStatePIIO]

Kudos to #PIIO, @OhioStateMedOnc faculty recruit Dr. Tim Gauntner, who rec'd a 2024 @ConquerCancerFd Young Investigator Award. W/ interests in #genitourinary #oncology, he works in the areas of #immune regulation in the #TME, steroid hormone signaling, & hormonal carcinogenesis.

[Cancer Center Catchment Area @cancer_area]

Female breast cancer incidence rate. Ohio ranked #9 in the nation

[Johns Hopkins Epidemiology @JohnsHopkinsEPI]

.@JohnsHopkins invites applications and nominations for the position of Editor-in-Chief (EiC) of a new open access (OA), online-only, peer-reviewed epidemiology journal, AJE Open, part of the American Journal of Epidemiology. https://t.co/f81Jmd5RPE

[NCI Cancer Stats @NCICancerStats]

The rate of new HR-/HER2- (or “triple-negative”) #BreastCancer cases is higher than average for Non-Hispanic Black women. The average rate of new cases increased across all racial and ethnic groups from 2016 to 2021. SEER*Explorer has more stats: https://t.co/ANRZCA8cR3 #BCSM

[JNCI @JNCI_Now]

Commentary by Manz and Barnett discusses the role of “linchpin” oncologists, central to patients in cancer care referral networks such as rural and low SES communities.

Read more here: https://t.co/xs9AYWexzG @ml_barnett @DanaFarber @harvardmed @HarvardChanSPH

[Vivek Subbiah, MD @VivekSubbiah]

⭐️Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies @AACR @CCR_AACR @CRC_AACR https://t.co/WvTjvgNftP